Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Tuberculosis

Free Subscription Articles published in Am J Respir Crit Care Med Retrieve available abstracts of 60 articles: HTML format Text format

Single Articles

August 2019
1. SCHAAF HS, Marais BJ
   The Role of Xpert MTB/RIF Ultra in Diagnosing Pulmonary Tuberculosis in Children.
   Am J Respir Crit Care Med. 2019 Aug 6. doi: 10.1164/rccm.201907-1492.
   PubMed     Text format    
   
   
   
2. ZAR HJ, Workman LJ, Prins M, Bateman LJ, et al
   Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.
   Am J Respir Crit Care Med. 2019 Aug 5. doi: 10.1164/rccm.201904-0772.
   PubMed     Text format     Abstract available
   
   
   May 2019
3. NIEDERMAN MS, Nair GB, Matt U, Herold S, et al
   Update in Lung Infections and Tuberculosis 2018.
   Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201903-0606.
   PubMed     Text format    
   
   
   April 2019
4. KRANZER K, Kalsdorf B, Heyckendorf J, Andres S, et al
   New WHO Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?
   Am J Respir Crit Care Med. 2019 Apr 26. doi: 10.1164/rccm.201902-0260.
   PubMed     Text format    
   
   
   January 2019
5. DHEDA K, Lenders L, Srivastava S, Magombedze G, et al
   Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.
   Am J Respir Crit Care Med. 2019 Jan 29. doi: 10.1164/rccm.201807-1361.
   PubMed     Text format     Abstract available
   
   
   
6. TE BRAKE LHM, Boeree MJ, Aarnoutse RE
   Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
   Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201811-2101.
   PubMed     Text format    
   
   
   
7. VELASQUEZ GE, Brooks MB, Coit JM, Sanchez Garavito E, et al
   Reply to: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
   Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201812-2281.
   PubMed     Text format    
   
   
   October 2018
8. SCHLUGER NW
   Tuberculosis Elimination, Research, and Respect for Persons.
   Am J Respir Crit Care Med. 2018 Oct 19. doi: 10.1164/rccm.201809-1623.
   PubMed     Text format    
   
   
   
9. KESHAVJEE S, Amanullah F, Cattamanchi A, Chaisson R, et al
   Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
   Am J Respir Crit Care Med. 2018 Oct 18. doi: 10.1164/rccm.201806-1053.
   PubMed     Text format     Abstract available
   
   
   
10. MARTINEZ L, Andrews JR
    Improving Tuberculosis Case Finding in Persons Living with Advanced HIV through New Diagnostic Algorithms.
    Am J Respir Crit Care Med. 2018 Oct 1. doi: 10.1164/rccm.201809-1702.
    PubMed     Text format    
    
    
    September 2018
11. YOON C, Semitala FC, Asege L, Katende J, et al
    Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Am J Respir Crit Care Med. 2018 Sep 7. doi: 10.1164/rccm.201803-0490.
    PubMed     Text format     Abstract available
    
    
    August 2018
12. ELKINGTON PT, Bateman AC, Thomas GJ, Ottensmeier CH, et al
    Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.
    Am J Respir Crit Care Med. 2018 Aug 24. doi: 10.1164/rccm.201807-1250.
    PubMed     Text format    
    
    
    June 2018
13. VELASQUEZ GE, Brooks MB, Coit JM, Pertinez H, et al
    Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis: A Randomized Controlled Trial.
    Am J Respir Crit Care Med. 2018 Jun 29. doi: 10.1164/rccm.201712-2524.
    PubMed     Text format     Abstract available
    
    
    
14. DHEDA K, Lenders L, Magombedze G, Srivastava S, et al
    Drug Penetration Gradients Associated with Acquired Drug Resistance in Tuberculosis Patients.
    Am J Respir Crit Care Med. 2018 Jun 7. doi: 10.1164/rccm.201711-2333.
    PubMed     Text format     Abstract available
    
    
    April 2018
15. MONEDERO-RECUERO I
    Drug-resistant Tuberculosis in Europe. What are We Waiting for?
    Am J Respir Crit Care Med. 2018 Apr 18. doi: 10.1164/rccm.201803-0497.
    PubMed     Text format    
    
    
    
16. SULIMAN S, Thompson E, Sutherland J, Weiner Rd J, et al
    Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis.
    Am J Respir Crit Care Med. 2018 Apr 6. doi: 10.1164/rccm.201711-2340.
    PubMed     Text format     Abstract available
    
    
    March 2018
17. ABUBAKAR I, Gupta RK, Rangaka MX, Lipman M, et al
    Update in Tuberculosis and Non-tuberculous Mycobacteria 2017.
    Am J Respir Crit Care Med. 2018 Mar 14. doi: 10.1164/rccm.201801-0106.
    PubMed     Text format    
    
    
    
18. COX D, Keane J
    Platelets and Tuberculosis: Small Cells, Not So Innocent Bystanders.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201802-0279.
    PubMed     Text format    
    
    
    
19. GUNTHER G, van Leth F, Alexandru S, Altet N, et al
    Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201710-2141.
    PubMed     Text format     Abstract available
    
    
    February 2018
20. SCHWANDER S, Keane J
    Cause or Effect - the Elusive Role of Regulatory T Cells in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 28. doi: 10.1164/rccm.201802-0233.
    PubMed     Text format    
    
    
    
21. FOX KA, Kirwan DE, Whittington AM, Krishnan N, et al
    Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 8. doi: 10.1164/rccm.201710-2102.
    PubMed     Text format     Abstract available
    
    
    December 2017
22. ERNST JD
    Float Like Bacilli, STING Like a B: Type I Interferons in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Dec 20. doi: 10.1164/rccm.201712-2368.
    PubMed     Text format    
    
    
    
23. VARAINE F, Guglielmetti L, Mitnick CD
    Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.
    Am J Respir Crit Care Med. 2017;196:1490-1491.
    PubMed     Text format    
    
    
    
24. VAN LETH F, Gunther G, Hoffmann H, Lange C, et al
    Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.
    Am J Respir Crit Care Med. 2017;196:1489-1490.
    PubMed     Text format    
    
    
    
25. BARRY PM, Lowenthal P, True L, Henry L, et al
    Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.
    Am J Respir Crit Care Med. 2017;196:1488-1489.
    PubMed     Text format    
    
    
    November 2017
26. BENARD A, Sakwa I, Schierloh P, Colom A, et al
    B Cells Producing Type I Interferon Modulate Macrophage Polarization in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Nov 21. doi: 10.1164/rccm.201707-1475.
    PubMed     Text format     Abstract available
    
    
    October 2017
27. DIVANGAHI M, Behr MA
    Cracking the Vaccine Code in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Oct 18. doi: 10.1164/rccm.201707-1489.
    PubMed     Text format     Abstract available
    
    
    
28. MARTINEZ L, Handel A, Shen Y, Chakraburty S, et al
    A Prospective Validation of a Clinical Algorithm to Detect Tuberculosis in Child Contacts.
    Am J Respir Crit Care Med. 2017 Oct 16. doi: 10.1164/rccm.201706-1210.
    PubMed     Text format    
    
    
    
29. DHEDA K
    The Multistep Tuberculosis Diagnostic Cascade. More Than Meets the Eye.
    Am J Respir Crit Care Med. 2017;196:809-811.
    PubMed     Text format    
    
    
    September 2017
30. ROSSER A, Pareek M, Turapov O, Wiselka MJ, et al
    Differentially Culturable Tubercule Bacilli are Generated During Non-pulmonary Tuberculosis Infection.
    Am J Respir Crit Care Med. 2017 Sep 7. doi: 10.1164/rccm.201705-1048.
    PubMed     Text format    
    
    
    August 2017
31. LEWINSOHN D
    An Expanding Role for Environmental Microbes in Shaping the Immune Response to Infection with Mycobacterium Tuberculosis.
    Am J Respir Crit Care Med. 2017 Aug 25. doi: 10.1164/rccm.201708-1599.
    PubMed     Text format    
    
    
    
32. BANAEI N, Pai M
    Detecting New Mycobacterium Tuberculosis Infection: Time for a More Nuanced Interpretation of QuantiFERON Conversions.
    Am J Respir Crit Care Med. 2017 Aug 1. doi: 10.1164/rccm.201707-1543.
    PubMed     Text format    
    
    
    July 2017
33. ABUBAKAR I, Kloprogge F
    End of the Road for Adjunctive Vitamin D Therapy for Pulmonary Tuberculosis?
    Am J Respir Crit Care Med. 2017 Jul 31. doi: 10.1164/rccm.201707-1509.
    PubMed     Text format    
    
    
    
34. SCRIBA TJ, Carpenter C, Carrasco Pro S, Sidney J, et al
    Differential Recognition of Mtb-specific Epitopes as a Function of Tuberculosis Disease History.
    Am J Respir Crit Care Med. 2017 Jul 31. doi: 10.1164/rccm.201706-1208.
    PubMed     Text format     Abstract available
    
    
    
35. CLAYTON K, Polak ME, Woelk CH, Elkington P, et al
    Gene Expression Signatures in Tuberculosis Have Greater Overlap with Autoimmune Than Infectious Diseases.
    Am J Respir Crit Care Med. 2017 Jul 28. doi: 10.1164/rccm.201706-1248.
    PubMed     Text format    
    
    
    
36. NEMES E, Rozot V, Geldenhuys H, Bilek N, et al
    Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of M. tuberculosis Infection.
    Am J Respir Crit Care Med. 2017 Jul 24. doi: 10.1164/rccm.201704-0817.
    PubMed     Text format     Abstract available
    
    
    
37. LESSELLS RJ, Cooke GS, McGrath N, Nicol MP, et al
    Impact of Point-of-care Xpert MTB/RIF on Tuberculosis Treatment Initiation: A Cluster Randomised Trial.
    Am J Respir Crit Care Med. 2017 Jul 20. doi: 10.1164/rccm.201702-0278.
    PubMed     Text format     Abstract available
    
    
    
38. GANMAA D, Munkhzul B, Fawzi W, Spiegelman D, et al
    High-Dose Vitamin D3 During Tuberculosis Treatment in Mongolia: A Randomised Controlled Trial.
    Am J Respir Crit Care Med. 2017 Jul 10. doi: 10.1164/rccm.201705-0936.
    PubMed     Text format     Abstract available
    
    
    June 2017
39. METCALFE JZ, Streicher E, Theron G, Colman RE, et al
    Cryptic Micro-heteroresistance Explains M. tuberculosis Phenotypic Resistance.
    Am J Respir Crit Care Med. 2017 Jun 14. doi: 10.1164/rccm.201703-0556.
    PubMed     Text format     Abstract available
    
    
    
40. BURZYNSKI J
    The Use of Modeling to Compare Tuberculosis Dynamics in Four US States.
    Am J Respir Crit Care Med. 2017 Jun 13. doi: 10.1164/rccm.201705-0963.
    PubMed     Text format    
    
    
    
41. GRANDJEAN L
    Investigating the Pathogen Genomic Determinants of Tuberculosis Transmission.
    Am J Respir Crit Care Med. 2017;195:1418-1420.
    PubMed     Text format    
    
    
    
42. 
    Erratum: New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America: Now Comes the Hard Part.
    Am J Respir Crit Care Med. 2017;195:1540.
    PubMed     Text format    
    
    
    May 2017
43. SHRESTHA S, Hill AN, Marks SM, Dowdy DW, et al
    Comparing Drivers and Dynamics of Tuberculosis (TB) in California, Florida, New York and Texas.
    Am J Respir Crit Care Med. 2017 May 5. doi: 10.1164/rccm.201702-0377.
    PubMed     Text format     Abstract available
    
    
    
44. SHAH JA, Musvosvi M, Shey M, Horne DJ, et al
    A Functional TOLLIP Variant is Associated with BCG-Specific Immune Responses and Tuberculosis.
    Am J Respir Crit Care Med. 2017 May 2. doi: 10.1164/rccm.201611-2346.
    PubMed     Text format     Abstract available
    
    
    
45. SCHLUGER NW
    AJRCCM: 100-Year Anniversary. Focus on Tuberculosis.
    Am J Respir Crit Care Med. 2017;195:1112-1114.
    PubMed     Text format    
    
    
    
46. ALLINSON JP, Mackay AJ, Shah PL
    AJRCCM: 100-Year Anniversary. Special Historical Image Section: Tuberculosis Then and Now.
    Am J Respir Crit Care Med. 2017;195:1118-1123.
    PubMed     Text format    
    
    
    
47. VAN ZYL-SMIT RN, Esmail A, Bateman ME, Dawson R, et al
    Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.
    Am J Respir Crit Care Med. 2017;195:1171-1180.
    PubMed     Text format     Abstract available
    
    
    
48. WEDZICHA JA, Brochard LJ, Martinez FD, Martinez FJ, et al
    AJRCCM: 100-Year Anniversary. The Long View and the Fast Lane.
    Am J Respir Crit Care Med. 2017;195:1081-1085.
    PubMed     Text format    
    
    
    
49. SAEKI K, Watanabe S, Waseda Y, Kasahara K, et al
    Endobronchial Lesions of Mycobacterium abscessus Infection in an Immunocompromised Patient.
    Am J Respir Crit Care Med. 2017;195:e37-e38.
    PubMed     Text format    
    
    
    April 2017
50. DIACON AH, van Brakel E, Lounis N, Meyvisch P, et al
    Triplicate Sputum Cultures for Efficacy Evaluation of Novel Anti-tuberculosis Regimens.
    Am J Respir Crit Care Med. 2017 Apr 27. doi: 10.1164/rccm.201704-0796.
    PubMed     Text format    
    
    
    March 2017
51. DEDICOAT MJ, Gunther G, Crudu V, Duarte R, et al
    Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
    Am J Respir Crit Care Med. 2017 Mar 21. doi: 10.1164/rccm.201612-2585.
    PubMed     Text format    
    
    
    
52. STOUT JE, Dicks KV
    A Breath of Fresh Air for Patients with Pulmonary Nontuberculous Mycobacterial Infection.
    Am J Respir Crit Care Med. 2017;195:716-717.
    PubMed     Text format    
    
    
    February 2017
53. 
    What is Tuberculosis (TB)?
    Am J Respir Crit Care Med. 2017;195:P7-P8.
    PubMed     Text format    
    
    
    December 2016
54. NEBENZAHL-GUIMARAES H, van Laarhoven A, Farhat MR, Koeken VA, et al
    Transmissible Mycobacterium tuberculosis Strains Share Genetic Markers and Immune Phenotypes.
    Am J Respir Crit Care Med. 2016 Dec 20. doi: 10.1164/rccm.201605-1042.
    PubMed     Text format     Abstract available
    
    
    
55. DARTOIS V, Saito K, Warrier T, Nathan C, et al
    New Evidence for the Complexity of the Population Structure of Mycobacterium tuberculosis Increases the Diagnostic and Biologic Challenges.
    Am J Respir Crit Care Med. 2016;194:1448-1451.
    PubMed     Text format    
    
    
    November 2016
56. LEU JS, Chen ML, Chang SY, Yu SL, et al
    SP110b Controls Host Immunity and Susceptibility to Tuberculosis.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available
    
    
    
57. HARAUSZ EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, et al
    New/Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis: Practice-Based Recommendations.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available
    
    
    
58. GUGLIELMETTI L, Le Du D, Frechet-Jachym M, Mitnick C, et al
    Preventing Acquired Resistance to Bedaquiline and Delamanid in Multidrug-Resistant Tuberculosis Treatment Requires Optimal Management.
    Am J Respir Crit Care Med. 2016;194:1170-1171.
    PubMed     Text format    
    
    
    
59. SAUNDERS MJ, Datta S
    Contact Investigation: A Priority for Tuberculosis Control Programs.
    Am J Respir Crit Care Med. 2016;194:1049-1051.
    PubMed     Text format    
    
    
    October 2016
60. VARAINE F, Guglielmetti L, Huerga H, Bonnet M, et al
    Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.
    Am J Respir Crit Care Med. 2016;194:1028-1029.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: